Usrenty

ustekinumab · Biosimilar Collaborations Ireland Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Usrenty, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: EMA Authorised: Usrenty (ustekinumab) — Biosimilar Collaborations Ireland Limited